Tech Company Financing Transactions
Beaconcure Funding Round
On 6/14/2023, Beaconcure raised $14 million in Series B financing from NewVale Capital and private investors.
Transaction Overview
Company Name
Announced On
6/14/2023
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to to expand its commercial organization, and to bring its platform to the market.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Israel Beck st 34
Tel Aviv, Undisclosed
IL
Tel Aviv, Undisclosed
IL
Phone
Undisclosed
Website
Email Address
Overview
With Beaconcure, pharmaceutical companies and CROs can validate clinical trial data for regulatory approval while cutting submission timelines in half! By using 'Verify' by Beaconcure, any data inconsistency will be detected automatically during the QC process, reducing handling time and eliminating the possibility of an error-filled submission. In collaboration with Pfizer, Beaconcure algorithms are designed and trained to support all types of therapeutic areas and study sizes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yoran Bar
Chief Operating Officer
Ilan Carmeli
Vice President
Michael Rosen
Browse more venture capital transactions:
Prev: 6/14/2023: Pebble Mobility venture capital transaction
Next: 6/14/2023: MAJORITY venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs